| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Revenue | $2.2M | +67.2% |
| Cost of Revenue | $1.1M | +66.8% |
| Gross Profit | $1.1M | +67.7% |
| R&D Expense | $2.9M | -20.6% |
| SG&A Expense | $10.5M | +17.2% |
| Operating Income | -$14.0M | -10.2% |
| Interest Expense | $6.8M | +24.5% |
| Net Income | -$20.7M | -14.4% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Accounts Receivable | $756K | +185.3% |
| Inventory | $2.1M | +30.1% |
| Current Assets | $3.6M | +5.2% |
| Total Assets | $7.6M | +20.6% |
| Current Liabilities | $21.7M | +35.3% |
| Total Liabilities | $47.8M | +25.3% |
| Stockholders' Equity | -$40.2M | -26.2% |
| Line Item | 2024-02-29 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.0M | -3.0% |
| Capital Expenditures | $22K | -91.4% |
| Investing Cash Flow | $4K | +101.4% |
| Financing Cash Flow | $12.1M | +32.0% |
| Free Cash Flow | -$13.0M | -1.1% |
| — |
| EPS (Diluted) | $0.00 | — |